Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
NCT04855773
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- HIV Infections
- Sexually Transmitted Diseases
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 15 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Public Health Foundation Enterprises, Inc.
- Last updated on ClinicalTrials.gov
- September 28, 2022
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- San Francisco AIDS Foundation · San Francisco, CA
District of Columbia · 1
- Whitman-Walker Health · Washington D.C., DC
Florida · 1
- University of Miami · Miami, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.